close

Monsanto rejects Bayer buyout, again

1 min read
article image -

NEW YORK (AP) – Monsanto Tuesday rejected a second and richer takeover bid from Bayer.

The German drug and chemicals company last week boosted its offer from $62 billion, to about $65 billion, or $125 per share.

Monsanto Co., a seed company, called the revised offer inadequate, as it did the initial bid.

The St. Louis company said it remains open to talks with Bayer and others about a deal.

Bayer Tuesday said it was disappointed with the second rejection, and took a shot at the company in a written statement.

“The revised all-cash offer is a compelling opportunity and represents immediate and certain value for Monsanto shareholders amid recent weak business performance and Monsanto’s reduced mid-term outlook,” Bayer said.

It said it looked forward to further negotiations.

CUSTOMER LOGIN

If you have an account and are registered for online access, sign in with your email address and password below.

NEW CUSTOMERS/UNREGISTERED ACCOUNTS

Never been a subscriber and want to subscribe, click the Subscribe button below.

Starting at $3.75/week.

Subscribe Today